Market

Cancer therapeutics present strongest innovation pipeline in next five years, says GlobalData

Read more

Funding in pharma surges in December 2024, reached $69.8 mn

Read more

Type 1 diabetes market to reach $9.9 bn in 7MM by 2033

Read more

Veeda Group rebrands as Veeda Lifesciences

Read more

Anthem Biosciences files DRHP for Rs 3,395 cr IPO

Read more

Venus Remedies gains GMP certification for Antibiotic-Carbapenemm facility from Moldova’s health ministry

Read more

Eli Lilly’s Zepbound holds possibility to dominate obesity market

Read more

Mankind Pharma and Innovent Biologics partner to license and commercialise Sintilimab

Read more

Operating losses of e-pharmacies seen falling below 10 per cent next fiscal

Read more

Pharmaceutical data and analytics market to grow to $2.1 bn by 2028: GlobalData

Read more